Targeting the PrLD of EBNA1 inhibits the formation of protein aggregation, promotes alternative splicing of SRRM1, and inhibits the progression of nasopharyngeal carcinoma. This evidence concerns the gene SRRM1 and nasopharyngeal carcinoma.